FDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
136
FDA & Industry Veteran Brian E. Harvey, MD, PhD, Joins Thetis Pharmaceuticals as Senior Medical Director

BRANFORD, Conn., May 07, 2018 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing first-in-class, immuno-resolving small molecule drugs to treat inflammatory bowel disease (IBD), announced today that Brian E. Harvey, MD, PhD, has joined the company as Senior Medical Director.

“Our lead drug candidate TP-317 is a promising new therapeutic option for ulcerative colitis patients with mild-to-moderate disease as an alternative to escalation to biologics and other aggressive, immunosuppressive drugs. Dr. Harvey has extraordinary skill and experience as a regulator, clinician and industry executive, and will provide important leadership to move our program into clinical investigation. At FDA, he led the regulatory review and approval of important IBD products including Humira, Remicade and Lialda, enabling him to provide unique insight in this space,” said Gary Mathias, Chief Executive Officer.

Dr. Harvey commented, “I believe TP-317 has the potential to fundamentally change the IBD treatment paradigm. There is a high unmet medical need for safe, oral therapies to treat ulcerative colitis patients who are not well controlled on mesalamine, as an alternative to immunosuppressive agents. TP-317 represents a mechanistically novel approach that is based on activating innate pathways to resolve inflammation and promote mucosal healing, a major emerging focus of IBD medical management.”

About Brian Harvey Dr. Harvey brings to Thetis three decades of extensive experience as a clinician, regulator, pharmaceutical executive and patient advocate. Most recently, Dr. Harvey served as Vice President of U.S. Regulatory Strategy at Pfizer, with a key role in designing the successful Phase III pivotal trial for Xeljanz® for the treatment of ulcerative colitis. As Vice President of U.S. Regulatory Policy at Sanofi-Aventis, he established the company’s FDA Liaison Office and procedures for agency interactions. Prior to joining industry, Dr. Harvey worked at the U.S. Food & Drug Administration (FDA), most recently as Director of the Division of Gastroenterology Products, where he oversaw the review of important IBD drug and biological products. Throughout his FDA career, Dr. Harvey remained a practicing clinician at Anne Arundel Medical Center in Annapolis, Maryland. He completed his Gastroenterology Fellowship at Johns Hopkins and Internal Medicine Residency at Beth Israel Hospital-Harvard.

About Thetis Thetis is a biopharmaceutical company developing novel immuno-resolving therapies for the treatment of IBD. Leveraging its proprietary HEALER™ technology platform, Thetis unlocks the robust pharmacology of endogenous bioactive lipids, overcoming the stability, manufacturing, formulation and patentability hurdles that have limited their development as pharmaceutical agents. Thetis’ lead drug candidate, TP-317, is a proprietary new molecular entity that delivers Resolvin E1, an endogenous lipid autacoid that offers a new approach to IBD treatment based on promoting inflammation resolution and mucosal healing. TP-317 has the potential to be a safe, oral therapy for induction and maintenance of remission in ulcerative colitis patients that are not well controlled with first-line therapy, as an alternative to aggressive immunosuppressive agents.

For more information, please visit Thetis Pharmaceuticals’ website ( www.thetispharma.com ) and follow Thetis on Twitter (@thetispharma).

Contact Information Aaron Mathias, Director of Business Development amathias@thetispharma.com

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Do...c46a43d4f9

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 72

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
APEC's Shenzhen Signal Is Bigger Than a Two-Day Summit

Updated Category News Views 92

Shenzhen spent two days trying to turn regional anxiety into a workable agenda. The APEC CEO Summit 2026, held November 17 and 18 at the Qianhai International Convention Center, brought together more than 2,000 political and business leaders from all 21 APEC economies and 13 economies outside the group. That is a serious room, not a ceremonial photo line. Still, investors...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 81

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 65

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 15

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
S&P Global's December 8 Talk Puts Guidance in Focus

Updated Category News Views 71

A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 34

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading

Top 5 Most Recently Viewed Articles

Carvana's Stock Peaks at $187.37 Amid Renewed Investor Confidence

Updated Category News Views 79

Carvana's Impressive Stock Surge to 52-Week High Recently, Carvana Co (NYSE: CVNA) achieved a remarkable milestone by hitting a 52-week high of $187.37. This surge highlights a robust recovery for the online used car retailer, whose stock has skyrocketed by an impressive 377.82% over the past year. This surge in stock price signifies renewed investor confidence in...

Continue Reading
ABM Industries Closes Q3 with Strong Earnings and Growth Boost

Updated Category News Views 133

ABM Industries Reports Strong Q3 Earnings ABM Industries (NYSE: ABM) saw its share price jump nearly 7% following the announcement of its third quarter earnings, which exceeded analyst expectations and prompted an upgrade to its full-year guidance. This positive outcome underscores the company's resilience in a challenging market landscape. Robust Financial Performance In...

Continue Reading
Transforming Senior Care: Click Holdings Embraces Cryptocurrency

Updated Category News Views 144

Innovative Strategies in Senior Care by Click Holdings Limited Click Holdings Limited (NASDAQ: CLIK) is making headlines with its groundbreaking approach to enhancing senior care services. Based in Hong Kong, this company combines cutting-edge human resources solutions with innovative cryptocurrency strategies, aiming to redefine how care services operate in an evolving...

Continue Reading
Cypress Creek and Meta Join Forces for Major Solar Project

Updated Category News Views 360

Cypress Creek and Meta's Renewable Energy Partnership In an exciting development, Cypress Creek Renewables and Meta have reached a significant milestone through their new Environmental Attribute Purchase Agreement (EAPA). This agreement is set to pave the way for the construction of a massive 505MWdc solar facility named Hanson Solar. With a capacity of 396MWac, this...

Continue Reading
The Shipyard Sets Sail with San Diego Headquarters Expansion

Updated Category News Views 462

The Shipyard Sets Sail with San Diego Headquarters Expansion The Shipyard, one of the fastest-growing independent marketing agencies in the nation, has announced an exciting development. The agency is expanding its operations by opening a new headquarters located in downtown San Diego at 185 West F Street. This move signifies a deepening of their commitment to California,...

Continue Reading